Interactions of immunoliposomes with target cells.

Area of Science:

• Biotechnology and Nanomedicine
• Immunology and Cell Biology

Background:

• Liposomes are versatile drug delivery vehicles.
• Targeted delivery can enhance therapeutic efficacy and reduce side effects.
• Monoclonal antibodies can be used to target liposomes to specific cells.

Purpose of the Study:

• To investigate the cellular uptake mechanism of antibody-coated liposomes (immunoliposomes).
• To evaluate the potential of immunoliposomes as targeted drug delivery systems.
• To assess the influence of cellular internalization pathways on drug efficacy.

Main Methods:

• Covalent attachment of anti-H-2Kk monoclonal antibody (11-4.1) to liposomes.
• Incubation of immunoliposomes with H-2Kk-positive target cells (RDM-4 lymphoma) at different temperatures (4°C and 37°C).
• Assessment of immunoliposome uptake using protease treatment, cytochalasin B, 2-deoxyglucose, NaN3, and fluorescence microscopy.
• Evaluation of encapsulated drug (methotrexate and cytosine-beta-D-arabinofuranoside) efficacy in target vs. non-target cells, with and without chloroquine treatment.

Main Results:

• Immunoliposome uptake at 4°C was primarily surface binding, while uptake at 37°C involved active internalization, likely via endocytosis.
• Methotrexate encapsulated in immunoliposomes showed specific cytotoxicity against target cells, which was reversible by chloroquine.
• Cytosine-beta-D-arabinofuranoside showed no target-specific killing, suggesting lysosomal inactivation.

Conclusions:

• Immunoliposomes are internalized by target cells through an endocytic pathway.
• The efficacy of drugs delivered by immunoliposomes is influenced by their stability within the lysosomal system.
• Immunoliposomes show promise as targeted drug carriers, provided the encapsulated drug can overcome lysosomal degradation.